Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China · Delayed Price · Currency is CNY

29.34

+0.28 (0.96%)

Jul 3, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Preparations	677.86M	546.98M	649.61M	933.28M	973.90M
Preparations Growth	23.93%	-15.80%	-30.39%	-4.17%	-6.83%
API(Active Pharmaceutical Ingredients) and Intermediates	575.86M	747.44M	806.92M	607.17M	389.69M
API(Active Pharmaceutical Ingredients) and Intermediates Growth	-22.95%	-7.37%	32.90%	55.81%	69.31%
Featured Intermediates	139.94M	200.10M	149.68M	-	-
Featured Intermediates Growth	-30.07%	33.69%	-	-	-
Others	31.14M	43.36M	5.35M	8.09M	5.48M
Others Growth	-28.18%	710.59%	-33.85%	47.68%	31.19%
Pharmaceutical Excipients	-	-	14.30M	19.90M	11.31M
Pharmaceutical Excipients Growth	-	-	-28.13%	75.98%	13.34%
Total	1.42B	1.54B	1.63B	1.57B	1.38B
Total Growth	-7.35%	-5.41%	3.66%	13.62%	7.04%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	1.11B	1.14B	1.26B	1.45B	1.31B
China Growth	-2.61%	-9.17%	-13.48%	10.47%	4.00%
Overseas	314.27M	397.57M	370.42M	117.33M	66.76M
Overseas Growth	-20.95%	7.33%	215.71%	75.76%	151.10%
Total	1.42B	1.54B	1.63B	1.57B	1.38B
Total Growth	-7.35%	-5.41%	3.66%	13.62%	7.04%